This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

November 4–6, 2024Stockholm, Sweden

Jean-Patrick Hennebelle
SVP, Head of Global Late-Stage Partnering at IPSEN


Jean-Patrick Hennebelle joined Ipsen’s Global Partnering organization in 2015. Holding a number of positions of increasing responsibility within business development and alliance management, Jean- Patrick now leads Ipsen’s late-stage business development strategy as Senior Vice President, Late Stage Partnering. Within his role, Jean-Patrick is responsible for expanding Ipsen’s late-stage portfolio across the three Therapeutic Areas of Oncology, Rare Disease and Neuroscience through strong, global, collaborative partnerships.

Prior to joining Ipsen, Jean-Patrick held the roles of Business Development Manager and then Dermatology Business Unit Manager during which he oversaw licensing and acquisition deals for Laboratoires Expanscience. Before that, he worked for the biotechnology division of EFS (French Blood Service), during which he was responsible for key strategic alliances with partners in the U.S. and Asia for the provision of monoclonal antibodies. He started his career as Strategy Consultant for EY.

Jean-Patrick holds a Masters in Economic Sciences from I.A.E. Lille/University of Galway (Ireland). He also graduated as Executive Master in Corporate Finance from ESCP Europe.

Agenda Sessions

  • Late-stage deal strategies: case study of a late-stage deal in practice